Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus

被引:13
|
作者
Costa, Nadia Lago [1 ]
Goncalves, Julie Ane Maria [1 ]
de Lima, Sara Lia Goncalves [1 ]
de Arruda, Jose Alcides Almeida [2 ]
Miranda, Ana Carolina Campos [1 ]
Mesquita, Ricardo Alves [1 ,2 ]
da Silveira, Ericka Janine Dantas [3 ]
Batista, Aline Carvalho [1 ]
机构
[1] Univ Fed Goias, Sch Dent, Dept Stomatol Oral Med & Oral Pathol, Praca Univ S-N,Setor Univ, BR-74605220 Goiania, Go, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil
[3] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Odontol Sci, Natal, RN, Brazil
关键词
immunogenicity; immunohistochemical; lichen planus; mouth diseases; programmed cell death-1 ligand-2 protein; T-lymphocyte receptor; MALIGNANT-TRANSFORMATION; T-CELLS; EVASION MECHANISMS; EXPRESSION; MICROENVIRONMENT; PATHWAY; LESIONS; B7-DC;
D O I
10.1111/odi.13344
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective To investigate the expression of programmed death-ligands 1 and 2 (PD-L1, PD-L2), programmed death-1 (PD-1), CD8 and granzyme B (GrB), as well as its correlation with the severity of oral lichen planus (OLP). Materials and Methods In a collaborative study, 33 cases of OLP were evaluated according to the latest criteria proposed by the American Academy of Oral and Maxillofacial Pathology (AAOMP/2016) and were submitted to immunohistochemistry. Positivity was measured semiquantitatively (PD-L1, PD-L2) and quantitatively (PD-1, CD8, GrB). The severity of OLP was assessed according to clinical subtype, symptomatology and response to corticosteroid therapy. Results Most OLPs were considered to be negative for PD-L1 (66.6%), but high expression of PD-L2 (96.9%) by keratinocytes and immunoinflammatory cells was observed. PD-1(+) cell density/mm(2) was reduced compared to CD8(+) cells. A low cytotoxic immune response (CD8:GrB ratio) was also demonstrated. Interestingly, there were fewer GrB(+) cells in the intraepithelial region in reticular OLP compared to erosive/bullous OLP. Conclusions PD-L1/PD-1 pathways appear to be compromised in OLP due to low PD-L1 expression in most samples. In contrast, PD-L2 overexpression associated with a possible regulation of the cytotoxic immune response suggests an immune tolerance that may contribute to the chronic profile of OLP.
引用
收藏
页码:1246 / 1254
页数:9
相关论文
共 50 条
  • [31] Prognostic significance of PD-L1 and PD-L2 in breast cancer
    Baptista, Mauricio Z.
    Sarian, Luis Otavio
    Derchain, Sophie F. M.
    Pinto, Glauce A.
    Vassal, Jose
    HUMAN PATHOLOGY, 2016, 47 (01) : 78 - 84
  • [32] High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood
    Krueger, Kimberly
    Mayer, Zsuzsanna
    Gerckens, Miriam
    Boeck, Stefan
    Luppa, Peter
    Holdenrieder, Stefan
    BIOMEDICINES, 2022, 10 (10)
  • [33] Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma
    Ju, Feng
    Wang, Dawei
    Huang, Lan
    Jiang, Chun
    Gao, Ce
    Xiong, Cunquan
    Zhai, Guanghua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] Role of PD-L1 and PD-L2 in allergic diseases and asthma
    Singh, A. K.
    Stock, P.
    Akbari, O.
    ALLERGY, 2011, 66 (02) : 155 - 162
  • [35] PD-1/PD-L1 as a prognostic factor in leukemia
    Rezaeeyan, Hadi
    Hassani, Seyedeh Nafiseh
    Barati, Mojgan
    Shahjahani, Mohammad
    Saki, Najmaldin
    JOURNAL OF HEMATOPATHOLOGY, 2017, 10 (01) : 17 - 24
  • [36] PD-1/PD-L1 and DNA Damage Response in Cancer
    Kciuk, Mateusz
    Kolat, Damian
    Kaluzinska-Kolat, Zaneta
    Gawrysiak, Mateusz
    Drozda, Rafal
    Celik, Ismail
    Kontek, Renata
    CELLS, 2023, 12 (04)
  • [37] Assessment of PD-1 and PD-L1 tissue expression levels in lichen planus patients: a case–control study
    Maha Fathy Elmasry
    Rana Ahmed Mosaad
    Omar Ahmed Azzam
    Laila Ahmed Rashed
    Aya Fahim
    Archives of Dermatological Research, 316
  • [38] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [39] A snapshot of the PD-1/PD-L1 pathway
    Ghosh, Chinmoy
    Luong, Gary
    Sun, Yue
    JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
  • [40] PD-1/PD-L1 in cardiovascular disease
    Sun, YunFeng
    Li, Liang
    Wu, YaWei
    Yang, KePing
    CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30